Google
×
CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.
For questions about Investor Relations, please contact: USA. Rui Zhang. Phone: +1-240-864-2643. Email: ir@casipharmaceuticals.com. China. William Chen.
People also ask
CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States ...
Missing: investor relations
Jan 25, 2024 ˇ View the Most Current Investor Presentation Here. Contact Information. George Price Senior Vice President of Investor Relations (703) 841-7818
Missing: casi | Show results with:casi
The Company holds 80 % of the equity interests in CASI Wuxi and will invest, over time, $ 80 million in CASI Wuxi. The Company's investment will consist of (i) ...
The annual report can be accessed on the Company's investor relations website at https://www.casipharmaceuticals.com/investor-. PR Newswire•11 months ago ...
1 day ago ˇ CASI is currently involved in arbitration proceedings against Juventas in relation to Juventas's purported termination of the CNCT-19 Agreements ...
Missing: investor | Show results with:investor
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports ( ...
Apr 26, 2023 ˇ BEIJING, April 26, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. ... The annual report can be accessed on the Company's investor relations ...